The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
Open accessAbstract
Background— The role of osteoprotegerin in vascular disease is unclear. Recent observational studies show that serum osteoprotegerin levels are associated with the severity and progression of coronary artery disease, atherosclerosis, and vascular calcification in patients. However, genetic and treatment studies in mice suggest that osteoprotegerin may protect against vascular calcification. Methods and Results— To test whether osteoprotegerin induces or prevents vascular disease, we treated atherogenic diet–fed ldlr (−/−) mice with recombinant osteoprotegerin (Fc-OPG) or vehicle for 5 months. Vehicle-treated mice developed significant, progressive atherosclerosis with increased plasma osteoprotegerin levels, consistent with observational studies, and ≈15% of these atherosclerotic lesions developed calcified cartilage-like metaplasia. Treatment with Fc-OPG significantly reduced the calcified lesion area without affecting atherosclerotic lesion size or number, vascular cytokines, or plasma cholesterol levels. Treatment also significantly reduced tissue levels of aortic osteocalcin, a marker of mineralization. Conclusions— These data support a role for osteoprotegerin in the vasculature as an inhibitor of calcification and a marker, rather than a mediator, of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although OPG therapy consistently suppresses vascular calcification in animal models (127, 144, 166), there are minimal data on the effects of OPG therapy on atherogenesis or other aspects of vascular disease.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [166]
In the citing paper
“OPG treatment significantly reduced calcified lesion area in the aorta of these mice, without affecting atherosclerotic lesion size or number (166).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [166]
In the citing paper
“OPG had no effect on concentrations of inflammatory cytokines in the aorta or on plasma cholesterol levels.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citationOPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citationOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Self-citationStatistical data analysis in the computer age
Efron, B., & Tibshirani, R. (1991) · Science · doi:10.1126/science.253.5018.390 · Cited by 1,192
Bone Formation and Inflammation in Cardiac Valves
Mohler, E. R., Gannon, F. H., Reynolds, C. A., Zimmerman, R. A., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,067
Bone morphogenetic protein expression in human atherosclerotic lesions.
Boström, K. I., Watson, K. E., Horn, S. E. V., Wortham, C., Herman, I. M., & Demer, L. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116391 · Cited by 1,020
Self-citationAbedin, M., Tintut, Y., & Demer, L. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000133194.94939.42 · Cited by 865
Self-citationProudfoot, D., Skepper, J. N., Hegyi, L., Bennett, M. R., Shanahan, C. M., & Weissberg, P. L. (2000) · Circulation Research · doi:10.1161/01.res.87.11.1055 · Cited by 719
Cited by
Sorted by citations
Items 101–200 of 257
OPG/RANK/RANKL signaling system and its significance in nephrology.
Klejna, K., Naumnik, B., Gąsowska, K., & Myśliwiec, M. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0035-x · Cited by 37
Tumor necrosis factor superfamily molecules in acute coronary syndromes
Aukrust, P., Sandberg, W. J., Otterdal, K., Vinge, L. E., Gullestad, L. L., Yndestad, A., Halvorsen, B. L., & Ueland, T. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.523711 · Cited by 35
Nikolov, I. G., Mozar, A., Drüeke, T. B., & Massy, Z. A. (2009) · Blood Purification · doi:10.1159/000209248 · Cited by 34
Doehring, L. C., Heeger, C.-H. H., Aherrahrou, Z., Kaczmarek, P. M., Erdmann, J., Schunkert, H., & Ehlers, E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090758 · Cited by 34
Skeleton and Glucose Metabolism: A Bone-Pancreas Loop
Faienza, M. F., Luce, V., Ventura, A., Colaianni, G., Colucci, S. C., Cavallo, L., Grano, M., & Brunetti, G. (2015) · International Journal of Endocrinology · doi:10.1155/2015/758148 · Cited by 35
Targeting vascular calcification: softening-up a hard target
Kapustin, A. N., & Shanahan, C. M. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.004 · Cited by 34
Mechanisms linking osteoporosis with cardiovascular calcification
Demer, L. L., & Tintut, Y. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0008-1 · Cited by 33
Self-citationRegulatory circuits controlling vascular cell calcification
Sallam, T., Cheng, H., Demer, L. L., & Tintut, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1231-y · Cited by 34
Self-citationHiggins, C., Isbilir, S., Basto, P. A., Chen, I. Y., Vaduganathan, M., Vaduganathan, P., Reardon, M. J., Lawrie, G. M., Peterson, L. E., & Morrisett, J. D. (2015) · The Protein Journal · doi:10.1007/s10930-015-9620-3 · Cited by 33
Tseng, W., Graham, L. S., Geng, Y., Reddy, A., Lu, J., Effros, R. B., Demer, L. L., & Tintut, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117366 · Cited by 33
Self-citationChao, C., Yuan, T., Yeh, H., Chen, H., Huang, J., & Chen, H. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010805 · Cited by 31
The role of oxidized phospholipids in the development of disease
Nie, J. S., Yang, J., Wei, Y., & Wei, X. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100909 · Cited by 33
The association of insulin resistance with serum osteoprotegerin in obese adolescents
Suliburska, J., Bogdański, P., Gajewska, E., Kalmus, G., Sobieska, M., & Samborski, W. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0261-8 · Cited by 31
Platelet‐derived growth factor stimulates osteoprotegerin production in osteoblastic cells
McCarthy, H. S., Williams, J. H. H., Davie, M. W. J., & Marshall, M. J. E. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21600 · Cited by 30
Blassová, T., Tonar, Z., Tomášek, P., Hošek, P., Hollan, I., Třeška, V., & Moláček, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224818 · Cited by 28
Kuźniewski, M., Fedak, D., Dumnicka, P., Stępień, E. Ł., Kuśnierz‐Cabala, B., Cwynar, M., & Sułowicz, W. (2016) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.03.003 · Cited by 28
Schoppet, M., Kavurma, M. M., Hofbauer, L. C., & Shanahan, C. M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.117 · Cited by 27
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling
Quercioli, A., Montecucco, F., Bertolotto, M. B., Ottonello, L. C., Pende, A., Mach, F., & Dallegri, F. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02308.x · Cited by 26
Fibrotic Aortic Valve Stenosis in Hypercholesterolemic/Hypertensive Mice
Chu, Y., Lund, D. D., Doshi, H. H., Keen, H. L., Knudtson, K. L., Funk, N. D., Shao, J. Q., Cheng, J. L., Hajj, G. P., Zimmerman, K. A., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306912 · Cited by 26
Yılmaz, M. İ., Siriopol, D. C., Sağlam, M., Ünal, H. U., Karaman, M., Gezer, M., Kilinc, A., Eyileten, T., Guler, A. K., Aydın, İ., et al. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0136-4 · Cited by 26
Pacifico, L., Andreoli, G. M., D’Avanzo, M., Mitri, D. D., & Pierimarchi, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2073 · Cited by 25
Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms
Batmunkh, B., Kokubo, H., Kamata, R., Fujii, M., Yoshimura, K., Aoki, H., Orita, Y., Ishida, T., Ohtaki, M., Nagao, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147088 · Cited by 24
Pathophysiology of Aortic Stenosis and Mitral Regurgitation
Perrucci, G. L., Zanobini, M., Gripari, P., Songia, P., Alshaikh, B. A., Tremoli, E., & Poggio, P. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160020 · Cited by 25
Vitamin K2 regression aortic calcification induced by warfarin via Gas6/Axl survival pathway in rats
Jiang, X., Tao, H., Qiu, C., Ma, X., Li, S., Guo, X., Lv, A., & Li, H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.05.022 · Cited by 23
Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C
Rashid, G., Plotkin, E., Klein, O., Green, J., Bernheim, J., & Benchetrit, S. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00622.2007 · Cited by 23
Kim, C. S., Bae, E. H., Kwon, S., Han, S. H., Choi, K. H., Lee, J., Chae, D., Oh, K., Ahn, C., Kim, S. W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166792 · Cited by 22
Pereira, L., & Frazão, J. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.023 · Cited by 22
Alsalawy, A. M., Fathi, A., Kamel, R. A. M., & Ewis, I. (2011) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2011.10.002 · Cited by 20
Miyata, T., Minami, M., Kataoka, H., Hayashi, K., Ikedo, T., Yang, T., Yamamoto, Y., Yokode, M., & Miyamoto, S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015731 · Cited by 21
Giaginis, C., Papadopouli, A. E., Zira, A. N., Katsargyris, Α., Klonaris, C., & Theocharis, S. E. (2012) · Medical Science Monitor · doi:10.12659/msm.883485 · Cited by 20
Krzanowski, M., Krzanowska, K., Dumnicka, P., Gajda, M., Woziwodzka, K., Fedak, D., Grodzicki, T. K., Litwin, J. A., & Sułowicz, W. (2018) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12681 · Cited by 20
The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment
Vachey, C., Candellier, A., Toutain, S., & Mac‐Way, F. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00858-8 · Cited by 22
Davenport, C., Mahmood, W. A. W., Forde, H. E., Ashley, D. T., Agha, A., McDermott, J., Sreenan, S., Thompson, C. J., McGrath, F. P., McAdam, B. F., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1137 · Cited by 19
CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 Axis
Zhang, W.-B., Qi, Y.-F., Xiao, Z.-X., Chen, H., Liu, S.-H., Li, Z., Zeng, Z., & Wu, H. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10247-8 · Cited by 19
Bernardes, M., Vieira, T. S., Martins, M. J., Lucas, R., Costa, L. M. S. F., Pereira, J. G. L., Ventura, F., & Martins, E. (2017) · BioMed Research International · doi:10.1155/2017/6509754 · Cited by 19
He, Y., Zou, P., Lu, Y., Jia, D., Li, X., Yang, H., Tang, L., Zhu, Z., Tu, T., Tai, S., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.01.006 · Cited by 19
Biomolecules Orchestrating Cardiovascular Calcification
Tintut, Y., Honda, H. M., & Demer, L. L. (2021) · Biomolecules · doi:10.3390/biom11101482 · Cited by 19
Self-citationCianciolo, G., Manna, G. L., Donati, G., Dormi, A., Cappuccilli, M. L., Cuna, V., Legnani, C., Palareti, G., Colì, L., & Stefoni, S. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq421 · Cited by 19
Morony, S., Dwyer, D., Stolina, M., Kostenuik, P. J., Tintut, Y., Zhang, Z., Demer, L. L., Cattley, R. C., & Van, G. Y. (2008) · Circulation · doi:10.1161/circulationaha.108.782649 · Cited by 18
Self-citationThe Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease
Grigoropoulou, P., Eleftheriadou, I., Zoupas, C., & Tentolouris, N. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797535281 · Cited by 18
Znorko, B., Oksztulska-Kolanek, E., Michałowska, M., Kaminski, T. W., & Pawlak, K. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.08.001 · Cited by 19
Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Implications
Shioi, A., & Nishizawà, Y. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.015 · Cited by 18
Lef1 ablation alleviates cartilage mineralization following posttraumatic osteoarthritis induction
Elayyan, J., Carmon, I., Zecharyahu, L., Batshon, G., Maatuf, Y. H., Reich, E., Dumont, M., Kandel, L., Klutstein, M., & Dvir‐Ginzberg, M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116855119 · Cited by 17
Barchetta, I., Ceccarelli, V., Cimini, F. A., Bertoccini, L., Fraioli, A., Alessandri, C., Lenzi, A., Baroni, M. G., & Cavallo, M. G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0941-x · Cited by 17
Dekker, M., Waissi, F., Silvis, M. J. M., van Bennekom, J., Schoneveld, A. H., de Winter, R. J., Išgum, I., Leßmann, N., Velthuis, B. K., Pasterkamp, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98177-4 · Cited by 17
Mori, K., Jono, S., Emoto, M., Kawagishi, T., Yasumoto, H., Konishi, T., Furumitsu, Y., Shioi, A., Shoji, T., Inaba, M., et al. (2009) · Angiology · doi:10.1177/0003319708330525 · Cited by 17
Güngör, Ö., Kocyigit, I. D., Yılmaz, M. İ., & Sezer, S. (2017) · Seminars in Dialysis · doi:10.1111/sdi.12616 · Cited by 17
The use of denosumab in osteoporosis – an update on efficacy and drug safety
Diab, D. L., & Watts, N. B. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2386365 · Cited by 16
Ayina, C. N. A., Sobngwi, E., Essouma, M., Noubiap, J. J., Boudou, P., Ngoa, L. S. E., & Gautier, J. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0042-3 · Cited by 16
Lewis, J. R., Lim, W. H., Ueland, T., Wong, G., Zhu, K., Lim, E. M., Bollerslev, J., & Prince, R. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134266 · Cited by 16
Elseweidy, M. M., Mohamed, H. E., Elrashidy, R. A., Atteia, H. H., Elnagar, G. M., & Ali, A. A. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3438-1 · Cited by 16
Balmoș, I. A., Horváth, E., Brînzaniuc, K., Mureșan, A. V., Olah, P., Molnár, G. B., & Nagy, E. E. (2023) · Biomedicines · doi:10.3390/biomedicines11030881 · Cited by 15
Pesaro, A. E. P., Katz, M., Liberman, M., Pereira, C., Mangueira, C. L. P., de Carvalho, A. E. Z., Carvalho, K. S., Nomura, C. H., Franken, M., & Junior, C. V. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202738 · Cited by 15
The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular disease
Forde, H. E., Davenport, C., Harper, E., Cummins, P. M., & Smith, D. (2018) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000144 · Cited by 16
Ueland, T., Wilson, S. G., Islam, A. F. M., Mullin, B. H., Devine, A., Bollerslev, J., Zhu, K., & Prince, R. L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03605.x · Cited by 15
Chronic Kidney Disease-Mineral Bone Disorder
Moe, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00008-x · Cited by 15
Alves-Lopes, R., Neves, K. B., Strembitska, A., Harvey, A., Harvey, K. Y., Yusuf, H., Haniford, S., Hepburn, R., Dyet, J., Beattie, W., et al. (2021) · Clinical Science · doi:10.1042/cs20210643 · Cited by 12
Shinkov, A. D., Borissovа, A.-M., Kovatcheva, R. D., Atanassova, L. B., Vlahov, J. D., & Dakovska, L. N. (2014) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s15466 · Cited by 14
Deligiorgi, M. V., Panayiotidis, M. I., Siasos, G., & Trafalis, D. T. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200123151132 · Cited by 13
Chae, S. Y., Chung, W., Kim, Y. H., Oh, Y. K., Lee, J., Choi, K. H., Ahn, C., & Kim, Y. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e322 · Cited by 13
Quercioli, A., Viviani, G. L., Dallegri, F., Mach, F., & Montecucco, F. (2010) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e318200ec27 · Cited by 13
Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy
Nezami, N., Safa, J., Eftekharsadat, A., Salari, B., Ghorashi, S., Sakhaee, K., & Khosraviani, K. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.012 · Cited by 13
Malliga, D.-E., Wagner, D., & Fahrleitner‐Pammer, A. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0022-7 · Cited by 14
Denosumab in postmenopausal osteoporosis: what the clinician needs to know
Lewiecki, E. M. (2009) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x09343221 · Cited by 13
Systems Biology of Vascular Calcification
Sage, A., Tintut, Y., Garfinkel, A., & Demer, L. L. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.07.002 · Cited by 13
Self-citationHarper, E., Rochfort, K. D., Forde, H. E., Davenport, C., Smith, D., & Cummins, P. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188192 · Cited by 12
Klejna, K., Naumnik, B., Koc‐Żórawska, E., & Myśliwiec, M. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612463424 · Cited by 11
Genre, F., López‐Mejías, R., García-Bermúdez, M., Castañeda, S., González‐Juanatey, C., Llorca, J., Corrales, A., Ubilla, B., Miranda-Filloy, J. A., Pina, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106823 · Cited by 11
Dawson, S., & Lawrie, A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.017 · Cited by 11
Maddaloni, E., Nguyen, M., Shah, S. H., & Holman, R. R. (2024) · Diabetes Care · doi:10.2337/dc24-1455 · Cited by 10
Szulc, P., Chapurlat, R. D., & Hofbauer, L. C. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3213 · Cited by 10
Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients
Naumnik, B., Klejna, K., Koc‐Żórawska, E., & Myśliwiec, M. (2013) · Advances in Medical Sciences · doi:10.2478/ams-2013-0026 · Cited by 10
Albu, A., Bondor, C. I., Craciun, A. M., & Fodor, D. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.08.002 · Cited by 9
Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients
Németh, Z., Mardare, N., Czira, M. E., Deák, G., Kiss, I., Máthé, Z., Remport, Á., Újszászi, Á., Covic, A. C., Molnar, M. Z., et al. (2015) · Scientific Reports · doi:10.1038/srep14518 · Cited by 9
Significant Association between OPG/TNFRSF11B Variant and Common Complex Ischemic Stroke
Xiong, X., Naji, D. H., Wang, B., Zhao, Y., Wang, J., Wang, D., Zhang, Y., Li, S., Chen, S., Huang, Y., et al. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.01.029 · Cited by 9
Effects of osteoprotegerin/TNFRSF11B in two models of abdominal aortic aneurysms
Vorkapić, E., Kunath, A., & Wågsäter, D. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8936 · Cited by 9
ZHANG, Y., Liu, X., Li, K., & BAI, J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2153 · Cited by 9
Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice
Lu, J., Cheng, H., Atti, E., Shih, D. M., Demer, L. L., & Tintut, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.114 · Cited by 9
Self-citationGüneş, M., Temizkan, Ş., Apaydın, T., Ilgın, C., Haklar, G., & Yavuz, D. G. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108073 · Cited by 9
Changes of gene expression profiles across different phases of vascular calcification in rats
Jiang, Z., Wu, X. J., Liu, Y., Du, X. H., Shen, S., Xu, L., & Sun, W. (2013) · Genetics and Molecular Research · doi:10.4238/2013.november.26.4 · Cited by 8
Singh, D. K., Winocour, P. H., Summerhayes, B., Kaniyur, S., Viljoen, A., Sivakumar, G. S., & Farrington, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.08.006 · Cited by 8
Siller-Matula, J. M., Lang, I. M., Schoergenhofer, C., Roest, M., & Jilma, B. (2017) · Thrombosis and Haemostasis · doi:10.1160/th17-02-0087 · Cited by 7
Anti-Osteoporotic Drugs and Vascular Calcification: The Bidirectional Calcium Traffic
Yavropoulou, M. P., Pikilidou, M. I., & Yovos, J. G. (2013) · Journal of Vascular Research · doi:10.1159/000355204 · Cited by 8
Relationship Between Bone Cross-Sectional Area and Indices of Peripheral Artery Disease
Pedone, C., Scarlata, S., Napoli, N., Lauretani, F., Bandinelli, S., Ferrucci, L., & Incalzi, R. A. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9782-y · Cited by 7
LIS, G. J., Czubek, U., Jasińska, M., Jasek-Gajda, E., Łoboda, A., Dulak, J., Nessler, J., Sadowski, J., & Litwin, J. A. (2014) · PubMed · Cited by 7
Serum osteoprotegerin and renal function in the general population: the Tromsø Study
Vik, A., Brodin, E. E., Mathiesen, E. B., Brox, J. H., Jørgensen, L., Njølstad, I., Brækkan, S. K., & Hansen, J. (2016) · Clinical Kidney Journal · doi:10.1093/ckj/sfw095 · Cited by 7
Bakhireva, L. N., Laughlin, G. A., Bettencourt, R., & Barrett-Connor, E. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2624 · Cited by 7
Spartalis, M., Kasimatis, E., Liakou, E., Sampani, E., Λιούλιος, Γ., Christodoulou, M., Stai, S., Moysidou, E., Efstratiadis, G., & Papagianni, A. A. (2023) · Life · doi:10.3390/life13020454 · Cited by 6
Dolzhenko, A. T., Richter, T., & Сагаловски, С. (2016) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2016-44-4-513-534 · Cited by 6
The Role of Osteoprotegrin/Nuclear Factor kB Ligand in Coronary Collateral Development
Maghbooli, Z., Hossein‐Nezhad, A., Shirzad, M., & Behzadi, H. (2011) · European Journal of Inflammation · doi:10.1177/1721727x1100900109 · Cited by 5
Coronary Calcification and Hormones
Koulaouzidis, G., & Henein, M. (2011) · Angiology · doi:10.1177/0003319711399418 · Cited by 5
The role and mechanism of protein post‑translational modification in vascular calcification (Review)
Wang, D., Li, Q., & Xie, C. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12708 · Cited by 6
Golledge, J., Biroš, E., Clancy, P., Cooper, M. N., Palmer, L. J., & Norman, P. E. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.177 · Cited by 5
Suh, S. H., Oh, T. R., Choi, H. S., Kim, C. S., Oh, K., Lee, J., Oh, Y. K., Jung, J. Y., Choi, K. H., Kwon, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010178 · Cited by 5
Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
Chen, Y.-L., Huang, P.-Y., Tsai, J., Wang, J., & Hsu, B. (2023) · Medicina · doi:10.3390/medicina59101794 · Cited by 5
Secchiero, P., & Zauli, G. (2008) · Circulation · doi:10.1161/circulationaha.108.765776 · Cited by 5
Liu, T.-C., Hsu, C., Lee, W., Wang, S., Huang, C.-C., Lee, Y.-T., Fu, C.-M., Chen, J., & Li, L. (2023) · Pharmaceuticals · doi:10.3390/ph16020222 · Cited by 5
Zhu, Y., Wang, Y., Liu, X., Wang, Y., Cui, Z., Liu, F., & Hu, J. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131233 · Cited by 4
Kim, H. J., Seong, E. Y., & Song, S. H. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.061 · Cited by 4
Ayina, C. N. A., Boudou, P., Fidaa, I., Balti, E. V., Sobngwi, E., Ngoa, L. S. E., & Gautier, J. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.05.006 · Cited by 4
Metadata
- Authors
- Morony, S., Tintut, Y., Zhang, Z., Cattley, R. C., Van, G., Dwyer, D., Stolina, M., Kostenuik, P. J., & Demer, L. L.
- Affiliations
- Amgen (United States) (US)
- Venue
- Circulation
- Published
- 2008-01-22
- Volume
- 117
- Issue
- 3
- Pages
- 411-420
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC2680735
- OpenAlex
- W2073733302
- Cited by
- 258
- References
- 41
- Citations by year
- 2026: 9 · 2025: 1 · 2024: 9 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 11 · 2019: 8 · 2018: 12 · 2017: 14 · 2016: 18 · 2015: 19 · 2014: 14 · 2013: 17 · 2012: 19
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL081202, HL-081202)
- National Institute of General Medical Sciences (T32GM065823)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Keywords
- osteoprotegerin, vascular calcification, atherosclerosis, LDL receptor knockout mice, atherogenic diet, osteocalcin, coronary artery disease, vascular disease
- MeSH terms
- Animals, Aorta, Calcinosis, Endothelium, Vascular, Receptors, LDL, Recombinant Proteins, RNA, Messenger, Vascular Diseases, Mice, Knockout, Atherosclerosis, Mice, Osteoprotegerin, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
